InsideArbitrage Event Driven Monitor – March 14, 2023
Quick updates on the event driven strategies we follow on InsideArbitrage.
Subscribe to receive our Event Driven Monitor by email every morning before the market opens.
Merger Arbitrage
- Provention Bio (PRVB) to be acquired by Sanofi (SNY) for $1.64 billion or $25 per share in cash.
- Seagen (SGEN) to be acquired by Pfizer (PFE) for $43 billion or $229 per share in cash. We added SGEN as a potential deal in the works on February 26, 2023.
- Momentive Global (MNTV) to be acquired by a consortium led by Symphony Technology Group for $1.5 billion or $9.46 per share in cash. We added MNTV as a potential deal in the works on October 19, 2022.
Only plus or premium subscribers can access this post. Subscribe today.
